Precision BioSciences, Inc. Common Stock (DTIL) is a publicly traded Healthcare sector company. As of July 27, 2026, DTIL trades at $7.74 with a market cap of $188.10M and a P/E ratio of -3.41. DTIL moved +6.19% today. Year to date, DTIL is +64.93%; over the trailing twelve months it is +45.80%. Its 52-week range spans $3.53 to $9.62. Analyst consensus is strong buy with an average price target of $33.00. Rallies surfaces DTIL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
3 analysts cover DTIL: 0 strong buy, 3 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $33.00.
| Metric | Value |
|---|---|
| Price | $7.74 |
| Market Cap | $188.10M |
| P/E Ratio | -3.41 |
| EPS | $-2.14 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.62 |
| 52-Week Low | $3.53 |
| Volume | 439 |
| Avg Volume | 0 |
| Revenue (TTM) | $45.07M |
| Net Income | $-43.60M |
| Gross Margin | 0.00% |
3 analysts cover DTIL: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $33.00.